首页> 外文OA文献 >Expression of mucin 1 possessing a 3′-sulfated core1 in recurrent and metastatic breast cancer

【2h】

Expression of mucin 1 possessing a 3′-sulfated core1 in recurrent and metastatic breast cancer

机译：在复发和转移性乳腺癌中具有3'-硫酸化核心的粘蛋白1的表达

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hiroko Ideo; Yuji Hinoda; Kohei Sakai; Ikue Hoshi; Shigeru Yamamoto; Masaaki Oka; Kazunari Maeda; Noriko Maeda; Shoichi Hazama; Junko Amano; Katsuko Yamashita;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Expression of mucin 1 possessing a 3-sulfated core1 in recurrent and metastatic breast cancer [J] . Ideo Hiroko, Hinoda Yuji, Sakai Kohei, International Journal of Cancer =: Journal International du Cancer . 2015,第7期

机译：具有3-硫酸化core1的黏蛋白1在复发和转移性乳腺癌中的表达
2. International, phase 3 trial: Balixafortide (a CXCR4 antagonist) plus eribulin versus eribulin alone in patients with HER2 negative, locally recurrent or metastatic breast cancer (FORTRESS) international, phase 3 trial: Balixafortide (a CXCR4 antagonist) plus eribulin versus eribulin alone in patients with HER2 negative, locally recurrent or metastatic breast cancer (FORTRESS) [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：国际，第3阶段试验：Balixafortide（CXCR4拮抗剂）加二林蛋白与Eribulin单独服用Her2阴性，局部复发或转移性乳腺癌（堡垒）国际，第3阶段试验：Balixafortide（A CXCR4拮抗剂）加二林蛋白与二林林单独相反 HER2阴性，局部复发或转移性乳腺癌（堡垒）的患者
3. Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival? [J] . Altundag Kadri Breast cancer research and treatment. . 2017,第2期

机译：对复发性间隔较少或超过24个月的转移间隔，用于复发转移性乳腺癌和初级手术，用于脱诺转移性乳腺癌物质的存活吗？
4. Correlation Between Glycan Biomarkers of Human Breast Cancer and a Mouse Model of Metastatic Breast Cancer [C] . Maria Lorna A. de Leoz, Lawrence J. T. Young, Hyun Joo An, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2009

机译：人乳腺癌甘油生物标志物与转移性乳腺癌小鼠模型的相关性
5. Toll-like receptor (TLR) expression and function of immune system cells from metastatic breast cancer patients with circulating tumor cells. [D] . Green, Taryn Lindsey. 2013

机译：Toll样受体（TLR）的表达和具有循环肿瘤细胞的转移性乳腺癌患者免疫系统细胞的功能。
6. Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer? [O] . D J A Lobbezoo, R J W van Kampen, A C Voogd, 2015

机译：转移性乳腺癌的预后：从头和复发转移性乳腺癌患者之间是否有区别？
7. Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer? [O] . Lobbezoo, D.J.A., van Kampen, R.J.W., Voogd, A.C., 2015

机译：转移性乳腺癌的预后：从头和复发转移性乳腺癌患者之间是否有区别？
8. Elucidation of the Molecular Mechanisms for Aberrant Expression of Breast Cancer Specific Gene 1 in Invasive and Metastatic Breast Carcinomas [R] . Liu, J. 2005

机译：对侵袭性和转移性乳腺癌中乳腺癌特异性基因1异常表达的分子机制的阐述

Expression of mucin 1 possessing a 3′-sulfated core1 in recurrent and metastatic breast cancer

著录项

引文网络

相似文献

相关主题

期刊订阅